Novartis and Alcon Settle FCPA Violations for $345 Million (Part I of III)
Novartis and Alcon (a Novartis subsidiary at the time of misconduct) have agreed to pay a total of $345 million in criminal and civil penalties.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.